|
ES2218660T3
(es)
|
1996-01-16 |
2004-11-16 |
Bristol-Myers Squibb Company |
Inhibidores aromaticos conformacionalmente restringidos de la proteina de transferencia de trigliceridos microsomales y procedimiento.
|
|
US20040006011A1
(en)
|
1996-07-12 |
2004-01-08 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US20020168761A1
(en)
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
US5760246A
(en)
|
1996-12-17 |
1998-06-02 |
Biller; Scott A. |
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
|
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
DE60040676D1
(de)
|
1999-09-17 |
2008-12-11 |
Millennium Pharm Inc |
BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa
|
|
WO2001056989A2
(en)
|
2000-02-01 |
2001-08-09 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
WO2001083481A1
(en)
|
2000-04-27 |
2001-11-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
|
WO2002026712A2
(en)
|
2000-09-29 |
2002-04-04 |
Millennium Pharmaceuticals, Inc. |
Quaternary amines and related inhibitors of factor xa
|
|
WO2002034748A1
(fr)
|
2000-10-24 |
2002-05-02 |
Sankyo Company, Limited |
Derives d'imidazopyridine
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
US7129242B2
(en)
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
SE0100569D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
New compounds
|
|
EP1423388B1
(en)
|
2001-02-20 |
2008-12-03 |
AstraZeneca AB |
2-arylamino-pyrimidines for the treatment of gsk3-related disorders
|
|
JP2005520171A
(ja)
|
2001-04-10 |
2005-07-07 |
トランス テック ファーマ，インコーポレイテッド |
ドラッグディスカバリーに関する、プローブ、システム、および方法
|
|
WO2003000689A1
(en)
|
2001-06-21 |
2003-01-03 |
Smithkline Beecham Corporation |
Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
|
CA2450555A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
EP1270551A1
(en)
|
2001-06-26 |
2003-01-02 |
Aventis Pharma Deutschland GmbH |
Urea derivatives with antiproteolytic activity
|
|
US7868204B2
(en)
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
ES2262893T3
(es)
|
2001-10-05 |
2006-12-01 |
Smithkline Beecham Corporation |
Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
|
|
AU2002352663B2
(en)
|
2001-11-13 |
2007-06-21 |
Axys Pharmaceuticals, Inc. |
Cyanoalkylamino derivatives as protease inhibitors
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
|
GB0212049D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20040034084A1
(en)
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
|
CA2388358A1
(en)
|
2002-05-31 |
2003-11-30 |
Voiceage Corporation |
A method and device for multi-rate lattice vector quantization
|
|
JP3725105B2
(ja)
*
|
2002-08-30 |
2005-12-07 |
株式会社東芝 |
二次電池の過放電防止回路及び二次電池の過放電防止法
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
JP2006503082A
(ja)
|
2002-10-17 |
2006-01-26 |
メシルジーン、インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤
|
|
US20040087642A1
(en)
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
|
|
US20040092568A1
(en)
|
2002-10-31 |
2004-05-13 |
Zeldis Jerome B. |
Methods for the treatment, prevention and management of macular degeneration
|
|
BR0316680A
(pt)
|
2002-11-28 |
2005-10-18 |
Schering Ag |
Pirimidinas inibidoras de chk, pdk e akt, sua produção e uso como agentes farmacêuticos
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
TW200418806A
(en)
*
|
2003-01-13 |
2004-10-01 |
Fujisawa Pharmaceutical Co |
HDAC inhibitor
|
|
TW200424174A
(en)
|
2003-02-06 |
2004-11-16 |
Hoffmann La Roche |
New TP diamide
|
|
US7208491B2
(en)
|
2003-02-07 |
2007-04-24 |
Hoffmann-La Roche Inc. |
N-monoacylated o-phenylenediamines
|
|
WO2004076452A1
(en)
|
2003-02-26 |
2004-09-10 |
Merck Sharp & Dohme Limited |
5,8-DIFLUOROIMIDAZO[1,2-a]PYRIDINES AS GABA-A α2/α3 LIGANDS FOR TREATING ANXIETY AND/OR DEPRESSION
|
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
JP2006520819A
(ja)
|
2003-03-06 |
2006-09-14 |
メルク エンド カムパニー インコーポレーテッド |
抗原虫薬イミダゾピリジン化合物
|
|
SI1611088T1
(sl)
|
2003-04-07 |
2009-12-31 |
Pharmacyclics Inc |
Hidroksamati kot terapevtska sredstva
|
|
US20050234066A1
(en)
|
2004-04-15 |
2005-10-20 |
Agouron Pharmaceuticals, Inc. |
Alpha substituted carboxylic acids
|
|
WO2004092145A1
(en)
|
2003-04-15 |
2004-10-28 |
Pfizer Inc. |
Alpha substituted carboxylic acid as ppar modulators
|
|
US20050187266A1
(en)
|
2003-04-15 |
2005-08-25 |
Pfizer Inc |
Alpha substituted carboxylic acids
|
|
JP4847868B2
(ja)
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
|
WO2005006945A2
(en)
|
2003-07-03 |
2005-01-27 |
The Salk Institute For Biological Studies |
Methods for treating neural disorders and compounds useful therefor
|
|
KR101153335B1
(ko)
|
2003-09-24 |
2012-07-05 |
메틸진 인코포레이티드 |
히스톤 데아세틸라제의 억제제
|
|
PT2213661E
(pt)
|
2003-09-26 |
2011-12-15 |
Exelixis Inc |
Moduladores de c-met e métodos de uso
|
|
AU2004288715A1
(en)
|
2003-11-06 |
2005-05-26 |
Celgene Corporation |
Methods of using and compositions comprising a JNK inhibitor for the treatment and management of asbestos-related diseases and disorders
|
|
US7524851B2
(en)
|
2003-12-05 |
2009-04-28 |
Robert Bosch Gesellschaft Fur Medizinische Forschung (Rbmf) |
Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy
|
|
WO2005060571A2
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Antiprotozoal imidazopyridine compounds
|
|
WO2005070180A2
(en)
|
2004-01-16 |
2005-08-04 |
Merck & Co., Inc. |
Coccidian parasite casein kinase i as a chemotherapeutic target for antiprotozoal agents
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
|
US20070093492A1
(en)
|
2004-03-09 |
2007-04-26 |
Weir-Torn Jiaang |
Pyrrolidine derivatives
|
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
AU2005225471B2
(en)
*
|
2004-03-26 |
2011-05-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
CA2564568A1
(en)
|
2004-04-20 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating inflammatory muscle disorders including myositis and muscular dystrophy
|
|
WO2005102318A1
(en)
|
2004-04-20 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating hiv related diseases
|
|
NZ550114A
(en)
|
2004-04-20 |
2011-02-25 |
Transtech Pharma Inc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
CA2564570A1
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating plasmodium related diseases
|
|
WO2005102326A2
(en)
|
2004-04-23 |
2005-11-03 |
Ab Science |
Use of c-kit inhibitors for treating renal diseases
|
|
US20070225293A1
(en)
|
2004-04-23 |
2007-09-27 |
Ab Science |
Use of C-Kit Inhibitors for Treating Fibrosis
|
|
CN1953982B
(zh)
*
|
2004-05-17 |
2011-07-06 |
泰博特克药品有限公司 |
4-取代-1,5-二氢-吡啶并[3,2-b]吲哚-2-酮
|
|
EP1746990A1
(en)
|
2004-05-18 |
2007-01-31 |
AB Science |
Use of mast cells inhibitors for treating patients exposed to chemical or biological weapons
|
|
WO2005115385A1
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating acne
|
|
WO2005115304A2
(en)
|
2004-05-24 |
2005-12-08 |
Ab Science |
Use of c-kit inhibitors for treating fibrodysplasia
|
|
US8193205B2
(en)
|
2004-07-28 |
2012-06-05 |
Janssen Pharmaceutica N.V. |
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
|
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
|
EP1804801A2
(en)
|
2004-10-15 |
2007-07-11 |
Biogen Idec MA, Inc. |
Methods of treating vascular injuries
|
|
ZA200704889B
(en)
|
2004-11-23 |
2008-09-25 |
Celgene Corp |
JNK inhibitors for treatment of CNS injury
|
|
AU2005311251A1
(en)
|
2004-12-01 |
2006-06-08 |
Devgen Nv |
5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the Kv family
|
|
NZ555474A
(en)
|
2004-12-17 |
2010-10-29 |
Astrazeneca Ab |
4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
|
|
US20080167314A1
(en)
|
2004-12-28 |
2008-07-10 |
Osamu Uchikawa |
Condensed Imidazole Compound And Use Thereof
|
|
EP1841766A1
(en)
|
2005-01-19 |
2007-10-10 |
Biolipox AB |
Pyrrolopyridines useful in the treatment of inflammation
|
|
WO2006098912A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Merck & Co., Inc. |
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
US20080161305A1
(en)
|
2005-04-06 |
2008-07-03 |
Exelixis, Inc. |
C-Met Modulators and Methods of Use
|
|
NZ563866A
(en)
|
2005-05-09 |
2011-03-31 |
Achillion Pharmaceuticals Inc |
Thiazole compounds and methods of use
|
|
JP4528918B2
(ja)
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
|
MA28394B1
(fr)
|
2005-06-24 |
2007-01-02 |
Genelabs Tech Inc |
Derives d'heteroaryle pour traitement des virus
|
|
US7309787B2
(en)
|
2005-07-13 |
2007-12-18 |
Allergan, Inc. |
Kinase inhibitors
|
|
EP1904065A2
(en)
|
2005-07-14 |
2008-04-02 |
AB Science |
Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
|
|
AU2006287767B2
(en)
|
2005-09-07 |
2010-05-13 |
Merck Serono Sa |
IKK inhibitors for the treatment of endometriosis
|
|
AU2006296004B2
(en)
|
2005-09-27 |
2011-11-17 |
Shionogi & Co., Ltd. |
Sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
WO2007036732A1
(en)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
|
UY29827A1
(es)
|
2005-10-03 |
2007-05-31 |
Astrazeneca Ab |
2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones
|
|
ITMI20060296A1
(it)
|
2006-02-17 |
2007-08-18 |
Alberto Lodolo |
Dispositivo di intercettazione multifunzionale
|
|
EP1996233A2
(en)
|
2006-02-27 |
2008-12-03 |
Gilead Colorado, Inc. |
Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
|
|
CA2649861A1
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
EP2170882A1
(en)
|
2007-06-26 |
2010-04-07 |
Gilead Colorado, Inc. |
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
JP5640005B2
(ja)
|
2008-07-14 |
2014-12-10 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｄａｃおよび／またはｃｄｋ阻害剤としてのイミダゾシルピリジン化合物
|
|
NZ602832A
(en)
|
2008-07-14 |
2014-04-30 |
Gilead Sciences Inc |
Fused heterocyclic hdac inhibitor compounds
|
|
JP2011529504A
(ja)
|
2008-07-28 |
2011-12-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
シクロアルキリデンヒストン脱アセチル化酵素阻害剤化合物およびヘテロシクロアルキリデンヒストン脱アセチル化酵素阻害剤化合物
|
|
KR20120031170A
(ko)
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
|
|
WO2010144378A2
(en)
|
2009-06-08 |
2010-12-16 |
Gilead Colorado, Inc. |
Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
|